Prelude Capital Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-75,227
| Closed | -$2.03M | – | 1501 |
|
|
2024
Q2 | $2.03M | Buy |
+75,227
| New | +$2.03M | 0.14% | 159 |
|
|
2023
Q4 | – | Sell |
-15,371
| Closed | -$230K | – | 1321 |
|
|
2023
Q3 | $230K | Buy |
+15,371
| New | +$230K | 0.02% | 691 |
|
|
2023
Q2 | – | Sell |
-11,784
| Closed | -$461K | – | 1324 |
|
|
2023
Q1 | $461K | Sell |
11,784
-10,721
| -48% | -$420K | 0.03% | 433 |
|
|
2022
Q4 | $1.19M | Buy |
22,505
+12,789
| +132% | +$676K | 0.06% | 296 |
|
|
2022
Q3 | $437K | Buy |
9,716
+1,186
| +14% | +$53.3K | 0.02% | 689 |
|
|
2022
Q2 | $310K | Buy |
8,530
+2,113
| +33% | +$76.8K | 0.01% | 893 |
|
|
2022
Q1 | $265K | Sell |
6,417
-3,348
| -34% | -$138K | 0.01% | 880 |
|
|
2021
Q4 | $416K | Sell |
9,765
-799
| -8% | -$34K | 0.01% | 873 |
|
|
2021
Q3 | $581K | Buy |
10,564
+5,135
| +95% | +$282K | 0.01% | 606 |
|
|
2021
Q2 | $260K | Sell |
5,429
-144
| -3% | -$6.9K | 0.01% | 1013 |
|
|
2021
Q1 | $282K | Buy |
5,573
+299
| +6% | +$15.1K | 0.01% | 820 |
|
|
2020
Q4 | $332K | Sell |
5,274
-326
| -6% | -$20.5K | 0.01% | 486 |
|
|
2020
Q3 | $376K | Hold |
5,600
| – | – | 0.02% | 340 |
|
|
2020
Q2 | $235K | Buy |
+5,600
| New | +$235K | 0.01% | 467 |
|
|
2020
Q1 | – | Sell |
-93
| Closed | -$4K | – | 1679 |
|
|
2019
Q4 | $4K | Sell |
93
-315
| -77% | -$13.5K | ﹤0.01% | 1310 |
|
|
2019
Q3 | $13K | Buy |
+408
| New | +$13K | ﹤0.01% | 992 |
|